Y-mAbs Therapeutics Inc.

NASDAQ: YMAB · Real-Time Price · USD
8.52
0.01 (0.12%)
At close: Aug 15, 2025, 2:59 PM

Y-mAbs Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-11.7 -13.89 -2.23 -12.66
PEG Ratio
-0.32 0.18 -0.03 0.22
PS Ratio
3.96 3.51 3.27 20.06
PB Ratio
3.77 2.95 1.95 3.89
P/FCF Ratio
-22.09 -10.93 -2.81 -6.76
P/OCF Ratio
-22.09 -10.93 -2.81 -6.83
OCF/S Ratio
-0.18 -0.32 -1.16 -2.94
Debt / Equity Ratio
0.01 0.01 0.02 0.02
Quick Ratio
3.85 5.27 4.38 7.06
Current Ratio
4.16 5.52 4.61 7.26
Asset Turnover
0.73 0.66 0.46 0.16
Interest Coverage
n/a n/a -125.25 -62.33
Return on Equity
-0.32 -0.21 -0.87 -0.31
Return on Assets
-0.25 -0.17 -0.68 -0.26
Return on Invested Capital
-0.32 -0.24 -0.83 -0.62
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.83 0.87 0.88 0.93
Net Profit Margin
-0.34 -0.25 -1.46 -1.58
Pretax Profit Margin
-0.34 -0.25 -1.46 -1.58
Operating Profit Margin
-0.36 -0.3 -1.45 -3.31
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.35 -0.29 -1.45 -1.56